1. [OP.1B.05] CEREBROPROTECTIVE EFFECT OF AN ANGIOTENSIN TYPE 2 RECEPTOR AGONIST DELIVERED VIA THE INTRANASAL ROUTE AFTER STROKE. (September 2017) Authors: Sumners, C.; Bennion, D.; Jones, C.; Dang, A.; Isenberg, J.; Graham, J.; Waters, M.; Steckelings, U. Journal: Journal of hypertension Issue: Volume 35(2017)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [PP.34.37]: ACTIVITY OF BRAIN AND SERUM ANGIOTENSIN CONVERTING ENZYME 2 IS ALTERED IN THE ACUTE PHASE OF RAT AND HUMAN ISCHEMIC STROKE. (June 2015) Authors: Bennion, D.; Haltigan, E.; Irwin, A.; Rosado, C.; Purich, D.; Waters, M.; Sumners, C. Journal: Journal of hypertension Issue: Volume 33(2015)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Modulating of ocular inflammation with macrophage migration inhibitory factor is associated with notch signalling in experimental autoimmune uveitis. (17th November 2015) Authors: Yang, H.; Zheng, S.; Mao, Y.; Chen, Z.; Zheng, C.; Li, H.; Sumners, C.; Li, Q.; Yang, P.; Lei, B. Journal: Clinical and experimental immunology Issue: Volume 183:Number 2(2016:Feb.) Page Start: 280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗